Leocadi, Michela
Canu, Elisa
Paldino, Angela
Agosta, Federica
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Funding for this research was provided by:
H2020 European Research Council (StG2016_714388_NeuroTRACK)
Fondation Recherche Alzheimer
Article History
Received: 31 August 2022
Revised: 2 December 2022
Accepted: 3 December 2022
First Online: 13 December 2022
Declarations
:
: M. Leocadi and A. Paldino report no disclosures. E. Canu has received research supports from the Italian Ministry of Health. F. Agosta is Associate Editor of <i>NeuroImage: Clinical</i>, has received speaker honoraria from Roche and Biogen Idec, and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and the European Research Council. M. Filippi is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, Associate Editor of <i>Radiology</i>, and Associate Editor of <i>Neurological Sciences</i>; received compensation for consulting services and/or speaking activities from Alexion, Almirall, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Neopharmed Gentili, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: The manuscript does not contain clinical studies or patient data.
: The manuscript does not contain clinical studies or patient data.